雜志介紹

Acta Haematologica雜志介紹

《Acta Haematologica》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱血液學學報，本刊主要出版、報道醫(yī)學-HEMATOLOGY領域的研究動態(tài)以及在該領域取得的各方面的經(jīng)驗和科研成果，介紹該領域有關本專業(yè)的最新進展，探討行業(yè)發(fā)展的思路和方法，以促進學術信息交流，提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄，為該領域相關學科的發(fā)展起到了良好的推動作用，也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為1.7，最新CiteScore 指數(shù)為4.9。

本刊近期中國學者發(fā)表的論文主要有：

• Analysis of Efficacy and Prognostic Factors of CLAG Treatment in Chinese Patients with Refractory or Relapsed Acute Myeloid Leukemia.

  Author: Wang L¹, Xu J², Tian X², Lv T², Yuan G³.

• Effectiveness and Safety of Deferasirox in Thalassemia with Iron Overload: A Meta-Analysis.

  Author: Dou H¹, Qin Y², Chen G¹, Zhao Y¹.

• Hemophagocytic Lymphohistiocytosis during the Postpartum Stage of Pregnancy: A Report of Eight Cases.

  Author: Song Y¹, Wang JS¹, Wang YN¹, Wang Z².

• Acquired Factor V Inhibitor with Symptoms and Titer of Inhibitor Differences: Report of Two Cases.

  Author: Li F¹, Shu K¹, Liu J¹, Shen C¹, Wang X¹, Zhang Z¹, Jiang M².

英文介紹

Acta Haematologica雜志英文介紹

'Acta Haematologica' is a well-established and internationally recognized clinically-oriented journal featuring balanced, wide-ranging coverage of current hematology research. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis and differentiation is contained in first-rate basic and clinical papers some of which are accompanied by editorial comments by eminent experts. These are supplemented by short state-of-the-art communications, reviews and correspondence as well as occasional special issues devoted to ‘hot topics’ in hematology. These will keep the practicing hematologist well informed of the new developments in the field.